870 related articles for article (PubMed ID: 1280732)
21. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart.
Bian JS; Zhang WM; Pei JM; Wong TM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1065-70. PubMed ID: 10688624
[TBL] [Abstract][Full Text] [Related]
22. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological properties of the positive inotropic and alpha 1-adrenoceptor blocking agent saterinone.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Sep; 38(9):1287-92. PubMed ID: 2906245
[TBL] [Abstract][Full Text] [Related]
24. Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells.
Coqueret O; Boichot E; Lagente V
Clin Exp Allergy; 1997 Jul; 27(7):816-23. PubMed ID: 9249275
[TBL] [Abstract][Full Text] [Related]
25. Diazepam potentiates the effects of endogenous catecholamines on contractility and cyclic AMP levels in rat ventricular myocardium.
Marín J; Hernández J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):260-8. PubMed ID: 11919649
[TBL] [Abstract][Full Text] [Related]
26. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of Ro 20-1724 and isobutylmethylxanthine on the basal force of contraction and beta-adrenoceptor-mediated response in the rat ventricular myocardium.
Katano Y; Endoh M
Biochem Biophys Res Commun; 1990 Feb; 167(1):123-9. PubMed ID: 1689999
[TBL] [Abstract][Full Text] [Related]
28. High selectivity for inhibition of phosphodiesterase III and positive inotropic effects of MCI-154 in guinea pig myocardium.
Bethke T; Meyer W; Schmitz W; Scholz H; Wenzlaff H; Armah BI; Brückner R; Raap A
J Cardiovasc Pharmacol; 1993 Jun; 21(6):847-55. PubMed ID: 7687707
[TBL] [Abstract][Full Text] [Related]
29. Inotropic responses to selective (RO 20-1724 and SQ 65,442) and nonselective (trequinsin) inhibitors of cyclic AMP-specific class IV phosphodiesterase in newborn, immature, and adult rabbit myocardium.
Oquist NL; Strada SJ; Artman M
Pediatr Res; 1992 Mar; 31(3):300-4. PubMed ID: 1313959
[TBL] [Abstract][Full Text] [Related]
30. Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart.
Brunkhorst D; v der Leyen H; Meyer W; Nigbur R; Schmidt-Schumacher C; Scholz H
Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):575-83. PubMed ID: 2549430
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle.
Vargas ML; Hernandez J; Kaumann AJ
Br J Pharmacol; 2006 Jan; 147(2):158-63. PubMed ID: 16331293
[TBL] [Abstract][Full Text] [Related]
32. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
Muller B; Lugnier C; Stoclet JC
J Cardiovasc Pharmacol; 1990 Nov; 16(5):796-803. PubMed ID: 1703603
[TBL] [Abstract][Full Text] [Related]
33. Developmental changes in modulation of calcium currents of rabbit ventricular cells by phosphodiesterase inhibitors.
Akita T; Joyner RW; Lu C; Kumar R; Hartzell HC
Circulation; 1994 Jul; 90(1):469-78. PubMed ID: 7517800
[TBL] [Abstract][Full Text] [Related]
34. Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium.
Endoh M; Satoh H; Norota I; Hirano K; Hosokawa T
Heart Vessels; 1991; 6(3):158-67. PubMed ID: 1655692
[TBL] [Abstract][Full Text] [Related]
35. Mechanical and electrophysiological effects of milrinone on the force-frequency relationship in mammalian myocardium.
Mörner SE; Arlock P
Acta Physiol Scand; 1994 Feb; 150(2):125-32. PubMed ID: 8191891
[TBL] [Abstract][Full Text] [Related]
36. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.
Satoh H; Endoh M
Jpn J Pharmacol; 1990 Feb; 52(2):215-24. PubMed ID: 2156096
[TBL] [Abstract][Full Text] [Related]
37. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism.
Zhu WH; Majluf-Cruz A; Omburo GA
Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035
[TBL] [Abstract][Full Text] [Related]
38. Decreased inotropic but relatively preserved relaxation response to cyclic adenosine monophosphate-dependent agents in myopathic human myocardium.
Gutstein DE; Flemmal K; Bruce E; Travers KE; Gwathmey JK; Ransil BJ; Markis JE; Grossman W; Morgan JP
J Card Fail; 1996 Dec; 2(4):285-92. PubMed ID: 8989643
[TBL] [Abstract][Full Text] [Related]
39. Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea-pig hearts.
Bethke T; Meyer W; Schmitz W; Scholz H; Stein B; Thomas K; Wenzlaff H
Br J Pharmacol; 1992 Sep; 107(1):127-33. PubMed ID: 1384905
[TBL] [Abstract][Full Text] [Related]
40. Effect of milrinone on myocardial mechanical function and cyclic AMP content in the fetal rabbit.
Ogawa S; Nakanishi T; Kamata K; Takao A
Pediatr Res; 1987 Sep; 22(3):282-5. PubMed ID: 2443896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
